Showing 211-220 of 1665 results for "".
Currents: Updates and Innovations
https://practicaldermatology.com/programs/practical-dermatology/currents-updates-and-innovations/23832/The World Health Organization (WHO) will begin using “mpox” as a synonym for monkeypox. Both names will be used simultaneously for 1 year while “monkeypox” is phased out.5 Questions All Leaders Should Ask Themselves
https://practicaldermatology.com/topics/practice-management/5-questions-all-leaders-should-ask-themselves/23811/A happy and high-performing team can only be created by first-rate leadership.What Branding Is and Isn’t (and Why You Should Care)
https://practicaldermatology.com/topics/practice-management/what-branding-is-and-isnt-and-why-you-should-care/23776/Your brand will directly impact the kind of patients your practice attracts.SEO Myths About Duplicate Content
https://practicaldermatology.com/topics/practice-management/seo-myths-about-duplicate-content/23726/Issues around duplicate content can be surprisingly complex.Know Your Pigmented Lesions
https://practicaldermatology.com/youngmd-connect/resident-resource-center/know-your-pigmented-lesions/23560/A diagnostic challenge and review of a rare melanocytic lesion.Facelift Your Inventory Management
https://practicaldermatology.com/topics/practice-management/facelift-your-inventory-management/23546/Six recommendations to keep your inventory organized, accounted for, and secure.Recognizing and Treating Psoriasis in Skin of Color
https://practicaldermatology.com/columns/clinical-focus-1/recognizing-and-treating-psoriasis-in-skin-of-color/23493/Psoriasis may be more common across skin types than once believed.The Impact of Socioeconomic Status in Atopic Dermatitis and How the Internet Can Act as a Public Health Intervention
https://practicaldermatology.com/youngmd-connect/resident-resource-center/the-impact-of-socioeconomic-status-in-atopic-dermatitis-and-how-the-internet-can-act-as-a-public-health-intervention/23326/Management of Atopic Dermatitis During the COVID-19 Pandemic
https://practicaldermatology.com/topics/atopic-dermatitis/management-of-atopic-dermatitis-during-the-covid-19-pandemic/23322/There is concern about the immunosuppressive or immunomodulatory effects of oral and biologic medications in patients with skin disease.Biologics in Pediatric Dermatology
https://practicaldermatology.com/topics/psoriasis/biologics-in-pediatric-dermatology/23198/Younger patients are finally gaining access to a range of highly targeted treatments with lower risk profiles than their traditional alternatives.